GW Pharma Limited (United Kingdom) and Otsuka Pharmaceutical Co. Limited (Japan) have filed an International Patent Application for specific “Cannabinoids for the Treatment of Neuropathic Pain”!
The English Abstract is as follows:
“The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV) or tetrahydrocannabivarin (THCV). More preferably the phytocannabinoids are isolated and / or purified from cannabis plant extracts.”
This patent claims that it is a novel discovery, however, in the book “Cannabinoids and Terpenes: The Medicinal Benefits of Cannabis“, Ryder Management along with many other patients of medical cannabis, have known this for years.